Be part of the knowledge - Prova Education

Medical News

eurekalert.org
03/24/2023
Medical News
Cataract Surgery Reimbursements May Not Be Enough for Some Patients
Read more
medicalxpress.com
03/24/2023
Medical News
SARS‐CoV‐2 Infection During Pregnancy Linked to Higher Risk of Neurodevelopment…
Read more
webmd.com
03/24/2023
Medical News
Running Long Distances Might Not Hurt Your Joints After All
Read more

Popular

- Tanios S. Bekaii-Saab, MD
  Peer
- Joleen M. Hubbard, MD
  Peer
2
CME/CE
Molecular-Driven Treatment Advances in HER2+ Metastatic Colorectal Cancer
Molecular-Driven Treatment Advances in HER2+ Metastatic Colorectal Cancer
0.25 credits
Molecular-Driven Treatment Advances in HER2+ Metastatic Colorectal Cancer
0.25 credits
- Ezra Cohen, MD, FRCPSC, FASCO
  Peer
- Petr Szturz, MD, PhD
  Peer
0
CME/CE
Recent Advances and Emerging Approaches in the Treatment of Recurrent/Metastatic SCCHN: Matching the Patient to the Optimal Therapy
Recent Advances and Emerging Approaches in the Treatment of Recurrent/Metastatic SCCHN: Matching the Patient to the Optimal Therapy
0.25 credits
Recent Advances and Emerging Approaches in the Treatment of Recurrent/Metastati…
0.25 credits
- Sara W. Koblitz
  Peer
- Michael J. Thorpy, MD
  Peer
0
CME/CE
FDA “Tentative Approval” of Once-Nightly Sodium Oxybate: Not a “Product” Issue, but a “Patent” Issue on the Cusp
FDA “Tentative Approval” of Once-Nightly Sodium Oxybate: Not a “Product” Issue, but a “Patent” Issue on the Cusp
0.25 credits
FDA “Tentative Approval” of Once-Nightly Sodium Oxybate: Not a “Product” Issue,…
0.25 credits
- Jillian Ziemanski, OD, PhD, FAAO
  Peer
- Cynthia Matossian, MD, FACS
  Peer
2
CME/CE
Improving Meibomian Gland Dysfunction with Device Management
Improving Meibomian Gland Dysfunction with Device Management
0.25 credits
Improving Meibomian Gland Dysfunction with Device Management
0.25 credits
- Peter G. Pappas, MD, FACP
  Peer
- Thomas F. Patterson, MD, FACP, FIDSA
  Peer
2
CME/CE
Invasive Fungal Infections: More Common Than You Think
Invasive Fungal Infections: More Common Than You Think
0.25 credits
Invasive Fungal Infections: More Common Than You Think
0.25 credits
- Saad Z. Usmani, MD, MBA, FACP
  Peer
- Sikander Ailawadhi, MD
  Peer
- Amrita Krishnan, MD
  Peer
2
CME/CE Broadcast Replay
CME/CE Broadcast Replay
BCMA Who and When: Immunotherapies in Patients with RRMM
BCMA Who and When: Immunotherapies in Patients with RRMM
1.00 credit
BCMA Who and When: Immunotherapies in Patients with RRMM
1.00 credit
- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
5
Minute CME/CE™
Importance & Benefits of Early Diagnosis
Importance & Benefits of Early Diagnosis
1.00 program credit
Importance & Benefits of Early Diagnosis
1.00 program credit
- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
2
Minute CME/CE™
The Role of Biomarkers in Alzheimer's Disease
The Role of Biomarkers in Alzheimer's Disease
1.00 program credit
The Role of Biomarkers in Alzheimer's Disease
1.00 program credit

CME/CE

- Barbara Burtness, MD
  Peer
- Nabil F. Saba, MD, FACP
  Peer
2
CME/CE
Personalizing the Treatment of Recurrent/Metastatic HNSCC: A Multifactorial Path
Personalizing the Treatment of Recurrent/Metastatic HNSCC: A Multifactorial Path
0.25 credits
Personalizing the Treatment of Recurrent/Metastatic HNSCC: A Multifactorial Path
0.25 credits
- Danielle Becker, MD, MS, FAES
  Peer
- Ahmed Abdelmoity, MD
  Peer
- Deborah Holder, MD
  Peer
- John Stern, MD
  Peer
0
CME/CE
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
0.25 credits
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Pati…
0.25 credits
- Andrew H. Lipsky, MD
  Peer
- Jacob D. Soumerai, MD
  Peer
- Catherine C. Coombs, MD
  Peer
0
CME/CE Broadcast Replay
CME/CE Broadcast Replay
Individualized Approaches in CLL/SLL: Meeting the Needs of Your Patients Now and Preparing for the Future
Individualized Approaches in CLL/SLL: Meeting the Needs of Your Patients Now and Preparing for the Future
1.00 credit
Individualized Approaches in CLL/SLL: Meeting the Needs of Your Patients Now an…
1.00 credit
- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
2
Minute CME/CE™
How to Make an Early Diagnosis
How to Make an Early Diagnosis
1.00 program credit
How to Make an Early Diagnosis
1.00 program credit
- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
2
Minute CME/CE™
Prevention of Alzheimer's Disease
Prevention of Alzheimer's Disease
1.00 program credit
Prevention of Alzheimer's Disease
1.00 program credit
- Marc E. Agronin, MD
  Peer
2
Minute CME/CE™
Pathology: Amyloid vs Tau
Pathology: Amyloid vs Tau
1.00 program credit
Pathology: Amyloid vs Tau
1.00 program credit

Clinical Practice

- Sara W. Koblitz
  Peer
- Michael J. Thorpy, MD
  Peer
9
CME/CE
“Tentative Approval”: Understanding the FDA Ruling on Once-Nightly Sodium Oxybate
“Tentative Approval”: Understanding the FDA Ruling on Once-Nightly Sodium Oxybate
0.25 credits
“Tentative Approval”: Understanding the FDA Ruling on Once-Nightly Sodium Oxyba…
0.25 credits
- Martin Pollak, MD
  Peer
- Susanne Nicholas, MD, MPH, PhD
  Peer
2
CME/CE
Talking Rare: Epidemiology and Pathogenesis of APOL1-Mediated Kidney Disease
Talking Rare: Epidemiology and Pathogenesis of APOL1-Mediated Kidney Disease
0.25 credits
Talking Rare: Epidemiology and Pathogenesis of APOL1-Mediated Kidney Disease
0.25 credits
- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
1
Minute CME/CE™
Additional Treatments for Alzheimer's Disease
Additional Treatments for Alzheimer's Disease
1.00 program credit
Additional Treatments for Alzheimer's Disease
1.00 program credit
- Ross M. Maltz, MD
  Peer
- Shail M. Govani, MD, MSc
  Peer
- Nana E. Bernasko, CRNP, WHNP-BC, DNP
  Peer
- Shubha Bhat, PharmD, MS, BCACP
  Peer
2
GI Insights
IBD and Biosimilars: What Healthcare Professionals Need to Know
IBD and Biosimilars: What Healthcare Professionals Need to Know
IBD and Biosimilars: What Healthcare Professionals Need to Know
- Floor J. Backes, MD
  Peer
3
CME/CE
Improving Outcomes in Patients with Ovarian Cancer: Multidisciplinary Patient-Centered Care
Improving Outcomes in Patients with Ovarian Cancer: Multidisciplinary Patient-Centered Care
0.25 credits
Improving Outcomes in Patients with Ovarian Cancer: Multidisciplinary Patient-C…
0.25 credits
- Kara B. Markham, MD
  Peer
3
CME/CE
Hemolytic Disease of the Fetus and Newborn (HDFN): What Pediatric Providers Need to Know When Managing Hemolytic Disease in Newborns (HDN)
Hemolytic Disease of the Fetus and Newborn (HDFN): What Pediatric Providers Need to Know When Managing Hemolytic Disease in Newborns (HDN)
0.25 credits
Hemolytic Disease of the Fetus and Newborn (HDFN): What Pediatric Providers Nee…
0.25 credits

Programs

- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
2
Minute CME/CE™
1.00 credit 10 episodes
Advancing Alzheimer’s Disease
1.00 credit 10 episodes
- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
2
Minute CME/CE™
Standard of Care
Standard of Care
1.00 program credit
Standard of Care
1.00 program credit
- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
2
Minute CME/CE™
Differences Among Agents
Differences Among Agents
1.00 program credit
Differences Among Agents
1.00 program credit
- Marc E. Agronin, MD
  Peer
- Richard S. Isaacson, MD
  Peer
4
Minute CME/CE™
What Is Immunotherapy?
What Is Immunotherapy?
1.00 program credit
What Is Immunotherapy?
1.00 program credit
- Charles P. Vega, MD
  Peer
- Kareen Y. Espino, MD
  Peer
6
Primary Care Today
Conversations in Health Equity: Practicing Cultural Humility in Latino Populations
Conversations in Health Equity: Practicing Cultural Humility in Latino Populations
Conversations in Health Equity: Practicing Cultural Humility in Latino Populati…
- Yelena Janjigian, MD
  Peer
- Sam Klempner, MD
  Peer
0
CME/CE
Emerging Evidence in Second-Line and Potential Considerations in First-Line aGC and GEJ cancers
Emerging Evidence in Second-Line and Potential Considerations in First-Line aGC and GEJ cancers
0.25 credits
Emerging Evidence in Second-Line and Potential Considerations in First-Line aGC…
0.25 credits